Xconomy National

Archives

by in

Entry	Author	Date	Location
Dendreon Names John Johnson CEO After Volatile Year	Arlene Weintraub	02/01/12	Seattle
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation	Luke Timmerman	01/27/12	Seattle
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms	Luke Timmerman	01/05/12	Seattle
Xconomy Seattle’s Top 12 Life Sciences Stories of the Year	Luke Timmerman	12/28/11	Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Dendreon Pulls In $125M By Selling Royalty Slice of Merck’s Hepatitis C Drug	Luke Timmerman	12/06/11	Seattle
Medivation, Astellas Prostate Cancer Drug Helps Men Live Longer; Shares Skyrocket	Luke Timmerman	11/03/11	San Francisco
Dendreon Shares Tank Again, Elias Joins Gates Foundation, Seattle Children’s Gets $50M, & More Seattle-Area Life Sciences News	Luke Timmerman	11/03/11	Seattle
Dendreon Edges Past Street Expectations With Third Quarter Provenge Sales, Shares Still Fall	Luke Timmerman	11/02/11	Seattle
The Cancer Drug Dark Ages Are Coming to an End	Luke Timmerman	10/31/11	National
Chris Henney, the Immunex and Dendreon Mover/Shaker, Makes Biotech Hall of Fame	Luke Timmerman	10/17/11	Seattle
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise	Luke Timmerman	09/19/11	National
The Immunex Impact: Join Steve Gillis, Chris Henney and Many More on Dec. 1	Luke Timmerman	09/15/11	Seattle
Dendreon Slashes 500 Jobs, Gates Foundation Adds Novartis Exec, Theraclone Tacks on $10M, & More Seattle-Area Life Sciences News	Luke Timmerman	09/15/11	Seattle
Dendreon Concentrates Job Cuts in Manufacturing, but Seattle Feels the Axe Too	Luke Timmerman	09/08/11	Seattle
Dendreon Whacks 500 Jobs, 25% of Workforce, After Missing Sales Goal	Luke Timmerman	09/08/11	Seattle
Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In	Luke Timmerman	09/08/11	Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	09/08/11	Seattle
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead	Luke Timmerman	09/06/11	National
Dendreon Wins FDA OK for Atlanta Provenge Factory, Completing National Network	Luke Timmerman	08/26/11	Seattle
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News	Luke Timmerman	08/25/11	Seattle
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug	Luke Timmerman	08/22/11	Seattle
Dendreon Adds Ex-ImClone CEO to Board	Luke Timmerman	08/22/11	Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs	Luke Timmerman	08/22/11	National
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News	Bruce V. Bigelow	08/11/11	San Diego
Dendreon’s Blow-Up, Epigenomics Leaves Town, Presage Adds $1.5M, & More Seattle-Area Life Sciences News	Luke Timmerman	08/11/11	Seattle
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus	Luke Timmerman	08/08/11	National
An Open Letter to Dendreon’s Chairman	Brad Loncar	08/05/11	Seattle
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall	Luke Timmerman	08/03/11	Seattle
Dendreon Misses Street Expectations, Plans Layoffs, Backs Away from Bullish Forecast	Luke Timmerman	08/03/11	Seattle
Page 1 of 9	next page »